IP Library Patent Application 11999610
Patent Application
App. No. 11/999,610

Method of analyzing for at least one allergy

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/999,610
Abstract

A method of using a diffusion-based, continuous-monitoring system to analyze the effect of an allergen on skin includes creating and maintaining a diffusion channel in an area of skin. The skin is contacted with an allergen. Information related to at least one antibody, histamine and/or leukotriene is continuously monitored for a desired duration via a diffusion-based, continuous-monitoring device. Information related to the at least one antibody, histamine and/or leukotriene is analyzed to determine the effect of the allergen on the skin.

Claims (41)

1 . A method of using a diffusion-based, continuous-monitoring system to analyze the effect of an allergen on skin, the method comprising the acts of:

creating at least one diffusion channel in an area of skin;

maintaining the at least one diffusion channel for a desired duration;

contacting the skin with at least one selected allergen;

continuously monitoring information related to at least one antibody, histamine, leukotriene and/or prostaglandins at the area of skin for the desired duration via a diffusion-based, continuous-monitoring device; and

analyzing the information related to the at least one antibody, histamine, leukotriene, and/or prostaglandins at the area of skin to determine the effect of the allergen on the skin.

2 . The method of claim 1 wherein the at least one diffusion channel is a plurality of diffusion channels.

3 . The method of claim 1 wherein the continuous time period is at least 8 hours.

4 . The method of claim 1 wherein the diffusion-based, continuous-monitoring system is an electrochemical-monitoring system.

5 . The method of claim 1 wherein the diffusion-based, continuous-monitoring system is an optical-monitoring system.

6 . The method of claim 1 wherein information related to the at least one antibody at the area of the skin is analyzed.

7 . The method of claim 1 wherein information related to the at least one histamine at the area of the skin is analyzed.

8 . The method of claim 1 wherein information related to the at least one leukotriene at the area of the skin is analyzed.

9 . A method of using a diffusion-based, continuous-monitoring system to analyze the effect of an on area of skin, the method comprising the acts of:

creating at least one diffusion channel in an area of skin;

topographically applying a hydrogel or liquid on the skin to assist in enhancing the diffusion of at least one antibody, histamine, leukotriene and/or prostaglandins;

maintaining the at least one diffusion channel for a desired duration;

positioning a diffusion-based, continuous monitoring device in communication with the hydrogel or liquid;

continuously monitoring information related to the at least one antibody, histamine, leukotriene and/or prostaglandins at the area of skin for the desired duration via the diffusion-based, continuous-monitoring device; and

analyzing the information related to the at least one antibody, histamine, leukotriene and/or prostaglandins at the area of skin to determine the effect of the allergen on the skin.

10 . The method of claim 9 wherein the hydrogel or liquid includes a diagnostic element to assist in analyzing production or release rate of the at least one antibody, histamine, leukotriene and/or prostaglandins at the area of skin.

11 . The method of claim 9 wherein the information includes production, rate of release and/or release time of the at least one antibody, histamine, leukotriene and/or prostaglandins.

12 . The method of claim 9 wherein the information related to the at least one antibody at the area of the skin is analyzed.

13 . The method of claim 9 wherein the information related to the at least one histamine at the area of the skin is analyzed.

14 . The method of claim 9 wherein the information related to the at least one leukotriene at the area of the skin is analyzed.

15 . A method of using a diffusion-based, continuous-monitoring system to analyze the effect of an allergen on skin, the method comprising the acts of:

providing a diffusion-based, continuous-monitoring device, the device including a communications interface that is adapted to connect with a receiving module via a communications link;

creating at least one diffusion channel in an area of skin;

maintaining the at least one diffusion channel for a desired duration;

continuously monitoring information related to at least one antibody, histamine, leukotriene and/or prostaglandins at the area of skin for the desired duration via the diffusion-based, continuous-monitoring device; and

analyzing the information related to the at least one antibody, histamine, leukotriene and/or prostaglandins at the area of skin to determine the effect of the allergen on the skin.

16 . The method of claim 15 further including transmitting information related to the at least one antibody, histamine, leukotriene and/or prostaglandins at the area of skin to the receiving module via the communications link.

17 . The method of claim 16 further including receiving instructions from the receiving module via the communications link directed to the information related to the at least one antibody, histamine, leukotriene and/or prostaglandins.

18 . The method of claim 15 wherein the information related to the at least one antibody at the area of the skin is analyzed.

19 . The method of claim 15 wherein information related to the at least one histamine at the area of the skin is analyzed.

20 . The method of claim 15 wherein information related to the at least one leukotriene at the area of the skin is analyzed.

21 . A method of using a diffusion-based, monitoring system to analyze the effect of an allergen on skin, the method comprising the acts of:

creating at least one diffusion channel in an area of skin;

maintaining the at least one diffusion channel for a desired duration;

contacting the skin with at least one selected allergen; and

analyzing information related to at least one antibody, histamine, leukotriene and/or prostaglandins at the area of skin to determine the effect of the allergen on the skin.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2016
From: BAYER HEALTHCARE LLC
To: ASCENSIA DIABETES CARE HOLDINGS AG
Reel/Frame 037880/0604 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE STATE INSIDE ASSIGNMENT DOCUMENT PREVIOUSLY RECORDED AT REEL: 020253 FRAME: 0740. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 22, 2015
From: REBEC, MIHAILO V.
To: BAYER HEALTHCARE LLC
Reel/Frame 037358/0991 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2007
From: REBEC, MIHAILO V.
To: BAYER HEALTHCARE LLC
Reel/Frame 020253/0740 →